NGN Capital

What is NGN Capital?

NGN Capital is a healthcare-focused venture capital firm that was established in 2003 and is based in New York, New York. They specialize in investments across various segments within healthcare, including life sciences, biotechnology, pharmaceuticals, medical devices, and healthcare services.

NGN Capital actively seeks to invest in companies that exhibit the potential to provide above-average returns in the private equity sector. Their investment strategy emphasizes later-stage investments, although they maintain the flexibility to invest in selected early-stage opportunities as well.

With investment amounts ranging between $3 million and $40.3 million, NGN Capital diversifies its portfolio not only by stage but also geographically, focusing predominantly on entities within the United States and Europe. NGN Capital is recognized for having a professional team and advisors who possess deep investment and management expertise in the healthcare and venture capital industries from globally leading institutions.

They operate with North American offices located in New York, NY, Greenwich, CT, and a European office situated in Heidelberg, Germany.

Their integrated approach combines significant sector knowledge and a comprehensive network, which positions them well for identifying and creating value in their investment pursuits.

With a comprehensive understanding of the challenges and opportunities within the healthcare market, NGN Capital endeavors to strategically allocate their resources and expertise to ventures that align with their thematic areas of interest within the healthcare sector and can potentially contribute to the advancement of medical services and innovation.